These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32049830)

  • 21. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.
    Albertsen IE; Larsen TB; Rasmussen LH; Overvad TF; Lip GY
    Drugs; 2012 Sep; 72(13):1755-64. PubMed ID: 22876779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of thromboprophylaxis with enoxaparin in medical inpatients.
    Montero Ruiz E; Baldominos Utrilla G; López Álvarez J; Santolaya Perrin R
    Thromb Res; 2011 Nov; 128(5):440-5. PubMed ID: 21880352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines.
    Abukhalil AD; Nasser A; Khader H; Albandak M; Madia R; Al-Shami N; Naseef HA
    Vasc Health Risk Manag; 2022; 18():701-710. PubMed ID: 36082196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients.
    Bhalla V; Abdel-Latif A; Bhalla M; Ziada K; Williams MV; Smyth SS
    Am J Cardiol; 2018 Oct; 122(7):1236-1243. PubMed ID: 30082040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formal and informal venous thromboembolism risk assessment and impact on prescribing of thromboprophylaxis: a retrospective cohort study.
    Kemp M; Chan AHY; Harrison J; Rogers H; Zhao A; Kaur H; Tang G; Yang E; Beyene K
    Int J Clin Pharm; 2023 Aug; 45(4):864-874. PubMed ID: 37074512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. A retrospective multicenter study.
    Nieto JA; Cámara T; Camacho I;
    Eur J Intern Med; 2014 Oct; 25(8):717-23. PubMed ID: 25091470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Event rates and risk factors for venous thromboembolism and major bleeding in a population of hospitalized adult patients with acute medical illness receiving enoxaparin thromboprophylaxis.
    Gal GL; Agnelli G; Darius H; Kahn SR; Owaidah T; Rocha AT; Zhai Z; Khan I; Djoudi Y; Ponomareva E; Cohen AT
    Eur J Intern Med; 2024 Mar; 121():48-55. PubMed ID: 38030465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
    MacDougall K; Spyropoulos AC
    Semin Respir Crit Care Med; 2021 Apr; 42(2):308-315. PubMed ID: 33548931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta.
    Atmakusuma TD; Tambunan KL; Sukrisman L; Effendi S; Rachman A; Setiawati A; Rinaldi I; Mulansari NA; Rajabto W; Nasution SA; Muhadi ; Aninditha T; Sedono R; Sugiarto A; Pitoyo CW; Paramitha D; Astoro NW; Nasution IR
    Acta Med Indones; 2015 Apr; 47(2):136-45. PubMed ID: 26260556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
    Spyropoulos AC; Ageno W; Cohen AT; Gibson CM; Goldhaber SZ; Raskob G
    Thromb Haemost; 2020 Jun; 120(6):924-936. PubMed ID: 32492724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial.
    Pai M; Lloyd NS; Cheng J; Thabane L; Spencer FA; Cook DJ; Haynes RB; Schünemann HJ; Douketis JD
    Implement Sci; 2013 Jan; 8():1. PubMed ID: 23279972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
    Fanikos J; Rao A; Seger AC; Piazza G; Catapane E; Chen X; Goldhaber SZ
    Am J Med; 2011 Dec; 124(12):1143-50. PubMed ID: 22114828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
    Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
    Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standard or extended-duration prophylaxis in medical patients? A review of the evidence.
    Stark JE; Smith WJ
    J Thromb Thrombolysis; 2011 Oct; 32(3):318-27. PubMed ID: 21553280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Nicol P; Vicaut E; Turpie AG; Yusen RD;
    Ann Intern Med; 2010 Jul; 153(1):8-18. PubMed ID: 20621900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.
    Farias-Eisner R; Horblyuk R; Franklin M; Lunacsek OE; Happe LE
    Curr Med Res Opin; 2009 May; 25(5):1081-7. PubMed ID: 19298219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.